Clarithromycin Hikma 500 mg Pulver zur Herstellung einer Infusionslösung Германия - немецкий - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

clarithromycin hikma 500 mg pulver zur herstellung einer infusionslösung

hikma farmaceutica (portugal), s.a. (8007071) - clarithromycinlactobionat - pulver zur herstellung einer infusionslösung - teil 1 - pulver zur herstellung einer infusionslösung; clarithromycinlactobionat (26579) 739,51 milligramm

Blenrep Европейский союз - немецкий - EMA (European Medicines Agency)

blenrep

glaxosmithkline (ireland) limited - belantamab mafodotin - multiples myelom - antineoplastische mittel - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.